Frequency of germline patghogenic mutation in breast cancer patients at high risk hereditary cancer.

被引：1
|
作者：
Shin, Hee-Chul
Han, Wonshik
Lee, Han-Byoel
Moon, Hyeong-Gon
Lee, Eunshin
Noh, Dong Young
机构：
[1] Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea
[2] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Surg, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e13110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13110
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
    Kwong, Ava
    Shin, Vivian Yvonne
    Ho, Cecilia Y. S.
    Au, Chun Hang
    Slavin, Thomas P.
    Weitzel, Jeffrey N.
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    [J]. BMC CANCER, 2020, 20 (01)
  • [32] Identifying Patients at Risk for Hereditary Breast Cancer
    Olbrys, Kathleen M.
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2013, 9 (01): : 66 - 67
  • [33] Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
    Litton, Jennifer K.
    Rugo, Hope S.
    Ettl, Johannes
    Hurvitz, Sara A.
    Goncalves, Anthony
    Lee, Kyung-Hun
    Fehrenbacher, Louis
    Yerushalmi, Rinat
    Mina, Lida A.
    Martin, Miguel
    Roche, Henri
    Im, Young-Hyuck
    Quek, Ruben G. W.
    Markova, Denka
    Tudor, Iulia C.
    Hannah, Alison L.
    Eiermann, Wolfgang
    Blum, Joanne L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 753 - 763
  • [34] Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
    Robson, Mark
    Im, Seock-Ah
    Senkus, Elzbieta
    Xu, Binghe
    Domchek, Susan M.
    Masuda, Norikazu
    Delaloge, Suzette
    Li, Wei
    Tung, Nadine
    Armstrong, Anne
    Wu, Wenting
    Goessl, Carsten
    Runswick, Sarah
    Conte, Pierfranco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (06): : 523 - 533
  • [35] Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
    Wappenschmidt, Barbara
    Hauke, Jan
    Faust, Ulrike
    Niederacher, Dieter
    Wiesmueler, Lisa
    Schmidt, Gunnar
    Gross, Evi
    Gehrig, Andrea
    Sutter, Christian
    Ramser, Juliane
    Rump, Andreas
    Arnold, Norbert
    Meindl, Alfons
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (04) : 410 - 429
  • [36] Frequency and covariates of chemoprevention use among women at high risk for breast cancer.
    Conley, Claire C.
    Rodriguez, Jennifer
    O'Neill, Suzanne C.
    Vadaparampil, Susan T.
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [37] Management of women at high risk for breast cancer.
    Costa, A
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1254S - 1255S
  • [38] Hereditary breast cancer - Risk assessment of patients with a family history of breast cancer
    Warner, E
    Heisey, RE
    Goel, V
    Carroll, JC
    McCready, DR
    [J]. CANADIAN FAMILY PHYSICIAN, 1999, 45 : 104 - 112
  • [39] Breast cancer risk and clinical implications for germline PTEN mutation carriers
    Ngeow, Joanne
    Sesock, Kaitlin
    Eng, Charis
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (01) : 1 - 8
  • [40] Breast cancer risk and clinical implications for germline PTEN mutation carriers
    Joanne Ngeow
    Kaitlin Sesock
    Charis Eng
    [J]. Breast Cancer Research and Treatment, 2017, 165 : 1 - 8
12345